The role of diclofenac sodium in the dimorphic transition in Candida albicans

Microbial Pathogenesis

Volumn 48, Issue 3-4, 2010, Pages 110-115

  Rashki Ghalehnoo, Zahra ^a   Rashki, Ahmad ^a,b   Najimi, Mohsen ^b   Dominguez, Angel ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b UNIVERSITY OF ZABOL   (Iran)

Author keywords

C. albicans; Diclofenac sodium; Inhibition of hypha formation; Non steroidal anti inflammatory drug

Indexed keywords

AGGLUTININ LIKE 3; CYCLIC AMP; DICLOFENAC; ELONGATION FACTOR 1; ENDOTHELIN CONVERTING ENZYME; FUNGAL PROTEIN; FUNGAL RNA; HYPHAL WALL PROTEIN 1; MESSENGER RNA; RAS1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANDIDA ALBICANS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; FUNGAL CELL; FUNGUS HYPHAE; INCUBATION TEMPERATURE; INCUBATION TIME; INHIBITION KINETICS; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CULTURE MEDIA; DICLOFENAC; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; FUNGAL PROTEINS; GENE EXPRESSION PROFILING; HYPHAE; MICROSCOPY; TEMPERATURE; TIME;

CANDIDA ALBICANS;

EID: 77649189438     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2009.12.003     Document Type: Article

References (58)

1. Whiteway M., and Bachewich C. Morphogenesis in Candida albicans. Annual Review of Microbiology 61 (2007) 529-553
2. Ghormade V., and Deshpande M.V. Fungal spore germination into yeast or mycelium: possible implications of dimorphism in evolution and human pathogenesis. Die Naturwissenschaften 87 (2000) 236-240
3. Amin A., Joshi M., and Deshpande M.V. Morphology-associated expression of NADP-dependent glutamate dehydrogenases during yeast-mycelium transition of a dimorphic fungus Benjaminiella poitrasii. Antonie van Leeuwenhoek 85 (2004) 327-334
4. Niimi M., Shepherd M.G., and Monk B.C. Differential profiles of soluble proteins during the initiation of morphogenesis in Candida albicans. Archives of Microbiology 166 (1996) 260-268
5. Mysiakina I.S., and Funtikova N.S. The role of sterols in morphogenetic processes and dimorphism in fungi. Mikrobiologiia 76 (2007) 5-18
6. Enloe B., Diamond A., and Mitchell A.P. A single-transformation gene function test in diploid Candida albicans. Journal of Bacteriology 182 (2000) 5730-5736
7. Chiew Y.Y., Shepherd M.G., and Sullivan P.A. Regulation of chitin synthesis during germ-tube formation in Candida albicans. Archives of Microbiology 125 (1980) 97-104
8. Chen J., Zhou S., Wang Q., Chen X., Pan T., and Liu H. Crk1, a novel Cdc2-related protein kinase, is required for hyphal development and virulence in Candida albicans. Molecular and Cellular Biology 20 (2000) 8696-8708
9. Schroppel K., Sprosser K., Whiteway M., Thomas D.Y., Rollinghoff M., and Csank C. Repression of hyphal proteinase expression by the mitogen-activated protein (MAP) kinase phosphatase Cpp1p of Candida albicans is independent of the MAP kinase Cek1p. Infection and Immunity 68 (2000) 7159-7161
10. Felk A., Kretschmar M., Albrecht A., Schaller M., Beinhauer S., Nichterlein T., et al. Candida albicans hyphal formation and the expression of the Efg1-regulated proteinases Sap4 to Sap6 are required for the invasion of parenchymal organs. Infection and Immunity 70 (2002) 3689-3700
11. Phan Q.T., Belanger P.H., and Filler S.G. Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infection and Immunity 68 (2000) 3485-3490
12. Jung W.H., and Stateva L.I. The cAMP phosphodiesterase encoded by CaPDE2 is required for hyphal development in Candida albicans. Microbiology (Reading, England) 149 (2003) 2961-2976
13. Wilson D., Tutulan-Cunita A., Jung W., Hauser N.C., Hernandez R., Williamson T., et al. Deletion of the high-affinity cAMP phosphodiesterase encoded by PDE2 affects stress responses and virulence in Candida albicans. Molecular Microbiology 65 (2007) 841-856
14. Bachewich C., Thomas D.Y., and Whiteway M. Depletion of a polo-like kinase in Candida albicans activates cyclase-dependent hyphal-like growth. Molecular Biology of the Cell 14 (2003) 2163-2180
15. Rademacher F., Kehren V., Stoldt V.R., and Ernst J.F. A Candida albicans chaperonin subunit (CaCct8p) as a suppressor of morphogenesis and Ras phenotypes in C. albicans and Saccharomyces cerevisiae. Microbiology (Reading, England) 144 Pt 11 (1998) 2951-2960
16. Zhao X., Oh S.H., Cheng G., Green C.B., Nuessen J.A., Yeater K., et al. ALS3 and ALS8 represent a single locus that encodes a Candida albicans adhesin; functional comparisons between Als3p and Als1p. Microbiology (Reading, England) 150 (2004) 2415-2428
17. Zhao X., Daniels K.J., Oh S.H., Green C.B., Yeater K.M., Soll D.R., et al. Candida albicans Als3p is required for wild-type biofilm formation on silicone elastomer surfaces. Microbiology (Reading, England) 152 (2006) 2287-2299
18. Stoldt V.R., Sonneborn A., Leuker C.E., and Ernst J.F. Efg1p, an essential regulator of morphogenesis of the human pathogen Candida albicans, is a member of a conserved class of bHLH proteins regulating morphogenetic processes in fungi. Embo Journal 16 (1997) 1982-1991
19. Alem M.A., and Douglas L.J. Effects of aspirin and other nonsteroidal anti-inflammatory drugs on biofilms and planktonic cells of Candida albicans. Antimicrobial Agents and Chemotherapy 48 (2004) 41-47
20. Dannhardt G., and Kiefer W. Cyclooxygenase inhibitors - current status and future prospects. European Journal of Medicinal Chemistry 36 (2001) 109-126
21. Harris S.G., Padilla J., Koumas L., Ray D., and Phipps R.P. Prostaglandins as modulators of immunity. Trends in Immunology 23 (2002) 144-150
22. Noverr M.C., Erb-Downward J.R., and Huffnagle G.B. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clinical Microbiology Reviews 16 (2003) 517-533
23. Noverr M.C., Phare S.M., Toews G.B., Coffey M.J., and Huffnagle G.B. Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins. Infection and Immunity 69 (2001) 2957-2963
24. Noverr M.C., Toews G.B., and Huffnagle G.B. Production of prostaglandins and leukotrienes by pathogenic fungi. Infection and Immunity 70 (2002) 400-402
25. Lee K.L., Buckley H.R., and Campbell C.C. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13 (1975) 148-153
26. Liu H., Kohler J., and Fink G.R. Suppression of hyphal formation in Candida albicans by mutation of a STE12 homolog. Science (New York, NY) 266 (1994) 1723-1726
27. Castilla R., Passeron S., and Cantore M.L. N-acetyl-d-glucosamine induces germination in Candida albicans through a mechanism sensitive to inhibitors of cAMP-dependent protein kinase. Cellular Signalling 10 (1998) 713-719
28. Buffo J., Herman M.A., and Soll D.R. A characterization of pH-regulated dimorphism in Candida albicans. Mycopathologia 85 (1984) 21-30
29. Fonzi W.A., and Irwin M.Y. Isogenic strain construction and gene mapping in Candida albicans. Genetics 134 (1993) 717-728
30. Brogden R.N., Heel R.C., Pakes G.E., Speight T.M., and Avery G.S. Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs 20 (1980) 24-48
31. Brooks P.M., and Day R.O. Nonsteroidal antiinflammatory drugs-differences and similarities. The New England Journal of Medicine 324 (1991) 1716-1725
32. Biswas S., Van Dijck P., and Datta A. Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans. Microbiology and Molecular Biology Reviews 71 (2007) 348-376
33. Brega E., Zufferey R., and Mamoun C.B. Candida albicans Csy1p is a nutrient sensor important for activation of amino acid uptake and hyphal morphogenesis. Eukaryotic Cell 3 (2004) 135-143
34. Vilella F., Herrero E., Torres J., and de la Torre-Ruiz M.A. Pkc1 and the upstream elements of the cell integrity pathway in Saccharomyces cerevisiae, Rom2 and Mtl1, are required for cellular responses to oxidative stress. Journal of Biological Chemistry 280 (2005) 9149-9159
35. Garcia-Rodriguez L.J., Valle R., Duran A., and Roncero C. Cell integrity signaling activation in response to hyperosmotic shock in yeast. FEBS Letters 579 (2005) 6186-6190
36. Doedt T., Krishnamurthy S., Bockmuhl D.P., Tebarth B., Stempel C., Russell C.L., et al. APSES proteins regulate morphogenesis and metabolism in Candida albicans. Molecular Biology of the Cell 15 (2004) 3167-3180
37. Hoyer L.L., Payne T.L., Bell M., Myers A.M., and Scherer S. Candida albicans ALS3 and insights into the nature of the ALS gene family. Current Genetics 33 (1998) 451-459
38. Green C.B., Zhao X., and Hoyer L.L. Use of green fluorescent protein and reverse transcription-PCR to monitor Candida albicans agglutinin-like sequence gene expression in a murine model of disseminated candidiasis. Infection and Immunity 73 (2005) 1852-1855
39. Hoyer L.L. The ALS gene family of Candida albicans. Trends in Microbiology 9 (2001) 176-180
40. Birse C.E., Irwin M.Y., Fonzi W.A., and Sypherd P.S. Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infection and Immunity 61 (1993) 3648-3655
41. Braun B.R., Head W.S., Wang M.X., and Johnson A.D. Identification and characterization of TUP1-regulated genes in Candida albicans. Genetics 156 (2000) 31-44
42. Sharkey L.L., McNemar M.D., Saporito-Irwin S.M., Sypherd P.S., and Fonzi W.A. HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1. Journal of Bacteriology 181 (1999) 5273-5279
43. Nobile C.J., Schneider H.A., Nett J.E., Sheppard D.C., Filler S.G., Andes D.R., et al. Complementary adhesin function in C. albicans biofilm formation. Current Biology 18 (2008) 1017-1024
44. Padovan A.C., Chaves G.M., Colombo A.L., and Briones M.R. A novel allele of HWP1, isolated from a clinical strain of Candida albicans with defective hyphal growth and biofilm formation, has deletions of Gln/Pro and Ser/Thr repeats involved in cellular adhesion. Medical Mycology (2009) 1-13
45. Liu H. Transcriptional control of dimorphism in Candida albicans. Current Opinion in Microbiology 4 (2001) 728-735
46. Lo H.J., Kohler J.R., DiDomenico B., Loebenberg D., Cacciapuoti A., and Fink G.R. Nonfilamentous C. albicans mutants are avirulent. Cell 90 (1997) 939-949
47. Jain P., Akula I., and Edlind T. Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors. Antimicrobial Agents and Chemotherapy 47 (2003) 3195-3201
48. Feng Q., Summers E., Guo B., and Fink G. Ras signaling is required for serum-induced hyphal differentiation in Candida albicans. Journal of Bacteriology 181 (1999) 6339-6346
49. Hazan I., and Liu H. Hyphal tip-associated localization of Cdc42 is F-actin dependent in Candida albicans. Eukaryotic Cell 1 (2002) 856-864
50. Ushinsky S.C., Harcus D., Ash J., Dignard D., Marcil A., Morchhauser J., et al. CDC42 is required for polarized growth in human pathogen Candida albicans. Eukaryotic Cell 1 (2002) 95-104
51. Braun B.R., Kadosh D., and Johnson A.D. NRG1, a repressor of filamentous growth in C. albicans, is down-regulated during filament induction. Embo Journal 20 (2001) 4753-4761
52. Murad A.M., d'Enfert C., Gaillardin C., Tournu H., Tekaia F., Talibi D., et al. Transcript profiling in Candida albicans reveals new cellular functions for the transcriptional repressors CaTup1, CaMig1 and CaNrg1. Molecular Microbiology 42 (2001) 981-993
53. Murad A.M., Leng P., Straffon M., Wishart J., Macaskill S., MacCallum D., et al. NRG1 represses yeast-hypha morphogenesis and hypha-specific gene expression in Candida albicans. Embo Journal 20 (2001) 4742-4752
54. Staab J.F., Bradway S.D., Fidel P.L., and Sundstrom P. Adhesive and mammalian transglutaminase substrate properties of Candida albicans Hwp1. Science 283 (1999) 1535-1538
55. Tsuchimori N., Sharkey L.L., Fonzi W.A., French S.W., Edwards J.E., and Filler S.G. Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells. Infection and Immunity 68 (2000) 1997-2002
56. Spellberg B.J., Ibrahim A.S., Avanesian V., Fu Y., Myers C., Phan Q.T., et al. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis. The Journal of Infectious Diseases 194 (2006) 256-260
57. Fu Y., Ibrahim A.S., Sheppard D.C., Chen Y.C., French S.W., Cutler J.E., et al. Candida albicans Als1p: an adhesin that is a downstream effector of the EFG1 filamentation pathway. Molecular Microbiology 44 (2002) 61-72
58. Loza L., Fu Y., Ibrahim A.S., Sheppard D.C., Filler S.G., and Edwards J.E. Functional analysis of the Candida albicans ALS1 gene product. Yeast 21 (2004) 473-482